WallStreetZenWallStreetZen

NASDAQ: NYXH
Nyxoah Sa Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NYXH past revenue growth

How has NYXH's revenue growth performed historically?
Company
47.25%
Industry
7.75%
Market
16.96%
NYXH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NYXH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NYXH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NYXH earnings and revenue history

Current Revenue
$4.8M
Current Earnings
-$48.0M
Current Profit Margin
-993.8%

NYXH Return on Equity

Current Company
-38.7%
Current Industry
11.1%
Current Market
188%
NYXH's Return on Equity (-38.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NYXH announces earnings.

NYXH Return on Assets

Current Company
-31.3%
Current Industry
7.2%
NYXH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NYXH Return on Capital Employed

Current Company
-37.3%
Current Industry
9.7%
NYXH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NYXH vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NYXH$4.73M-$41.92M-$46.97M+383.53%N/A
SMTI$64.99M$190.58k-$4.30M+61.93%N/A
UTMD$50.22M$26.46M$16.64M+3.64%-1.62%
ANGO$324.01M-$169.01M-$192.37M+9.57%N/A
PLSE$0.00-$42.37M-$42.21M-100.00%N/A
View Top Medical Stocks

NYXH earnings dates

Next earnings date
Jun 6, 2024

Nyxoah Sa Earnings & Revenue FAQ

What were NYXH's earnings last quarter?

On Invalid Date, Nyxoah Sa (NASDAQ: NYXH) reported Q4 2023 earnings per share (EPS) of -$0.42, up 23.03% year over year. Total Nyxoah Sa earnings for the quarter were -$12.10 million. In the same quarter last year, Nyxoah Sa's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Nyxoah Sa stock.

What was NYXH's earnings growth in the past year?

As of Q2 2024, Nyxoah Sa's earnings has grown year over year. Nyxoah Sa's earnings in the past year totalled -$46.97 million.

What is NYXH's earnings date?

Nyxoah Sa's earnings date is Invalid Date. Add NYXH to your watchlist to be reminded of NYXH's next earnings announcement.

What was NYXH's revenue last quarter?

On Invalid Date, Nyxoah Sa (NASDAQ: NYXH) reported Q4 2023 revenue of $2.03 million up 45.76% year over year. In the same quarter last year, Nyxoah Sa's revenue was $1.39 million.

What was NYXH's revenue growth in the past year?

As of Q2 2024, Nyxoah Sa's revenue has grown 47.25% year over year. This is 39.5 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.75%. Nyxoah Sa's revenue in the past year totalled $4.73 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.